.Innovent Biologics has helped make the scenario that its own checkpoint inhibitor-cytokine combinat...
.A stage 3 test of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) h...
.Five months after Rakovina Therapies turned toward expert system, the cancer-focused biotech has ac...
.Ascendis Pharma has become a potential risk to BioMarin's Voxzogo, mentioning period 3 growth ailme...
.Though Alkeus Pharmaceuticals' oral eye condition asset stopped working to dramatically lessen geog...
.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually effortless to overlook...
.Immune gate preventions are actually the superheroes of cancer treatment. Medications like Bristol ...
.Invite to recently's Chutes & Ladders, our roundup of considerable leadership hirings, firings a...
.Regeneron is back with long-term consequence for its LAG-3 prevention as well as PD-1 inhibitor com...
.AstraZeneca has shared an early look at the performance of its own internal antibody-drug conjugate...